Jacquemont, S., Curie, A., des Portes, V., Torrioli, M. G., Berry-Kravis, E., Hagerman, R. J., . . . Gomez-Mancilla, B. (2011). Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Science translational medicine, 3(64), 64ra1. https://doi.org/10.1126/scitranslmed.3001708
Citace podle Chicago (17th ed.)Jacquemont, Sébastien, et al. "Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the MGluR5 Antagonist AFQ056." Science Translational Medicine 3, no. 64 (2011): 64ra1. https://doi.org/10.1126/scitranslmed.3001708.
Citace podle MLA (9th ed.)Jacquemont, Sébastien, et al. "Epigenetic Modification of the FMR1 Gene in Fragile X Syndrome Is Associated with Differential Response to the MGluR5 Antagonist AFQ056." Science Translational Medicine, vol. 3, no. 64, 2011, p. 64ra1, https://doi.org/10.1126/scitranslmed.3001708.